Medical science liaisons (MSL) in the pharma industry were already at their limit pre-COVID. The challenge for MSLs is to identify the most efficient way to upskill their teams and add digital competencies without overloading them.
Nina Levin
Advertisement
Nina Levin is Vice President, Client Success at Within3.
Articles by Nina Levin
Advertisement
Latest Updated Articles
MSL Teams Need to Digitize, or Face Being Left BehindPublished: September 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer
2
Pharma Partnerships Expand as Eli Lilly Announces Strategic Collaborations with MeiraGTx and SanegeneBio
3
Wegovy Demonstrates Reduction in Liver Injury in MASH Patients
4
CMS Unveils Initiative to Cut Medicaid Drug Costs and Expand Access to Affordable Medications
5
